Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Bernstein

Showing results (161-170 of 379) with videos related to

Pageof 38
Sort By:
Antiviral Research|September 20, 2011
N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigsDavid I Bernstein, Fernando J Bravo, Jennifer R Clark, et al.
Journal of Women'S Health (2002)|October 19, 2016
Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young WomenDana Whittemore, Lili Ding, Lea E Widdice, et al.
The Journal of Infectious Diseases|August 29, 2012
Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humansRobert Frenck, David I Bernstein, Ming Xia, et al.
Vaccine|May 20, 2019
Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes diseaseDavid I Bernstein, Jessica B Flechtner, Lisa K McNeil, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 24, 2006
Specific fungal exposures, allergic sensitization, and rhinitis in infantsMelissa Osborne, Tiina Reponen, Atin Adhikari, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2008
Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivoDavid I Bernstein, Nathalie Goyette, Rhonda Cardin, et al.
Pediatrics|July 11, 2012
Vaccine-type human papillomavirus and evidence of herd protection after vaccine introductionJessica A Kahn, Darron R Brown, Lili Ding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2016
Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a CommunityJessica A Kahn, Lea E Widdice, Lili Ding, et al.
Allergy and Asthma Proceedings|January 6, 2021
Allergy to oak pollen in North AmericaDavid I Bernstein, Peter A Würtzen, Lawrence DuBuske, et al.
Vaccine|September 14, 2019
Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpesDavid I Bernstein, Rhonda D Cardin, Fernando J Bravo, et al.
Pageof 38

Showing results (161-170 of 379) with videos related to

Sort By:
Pageof 38
Antiviral Research|September 20, 2011
N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigsDavid I Bernstein, Fernando J Bravo, Jennifer R Clark, et al.
Journal of Women'S Health (2002)|October 19, 2016
Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young WomenDana Whittemore, Lili Ding, Lea E Widdice, et al.
The Journal of Infectious Diseases|August 29, 2012
Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humansRobert Frenck, David I Bernstein, Ming Xia, et al.
Vaccine|May 20, 2019
Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes diseaseDavid I Bernstein, Jessica B Flechtner, Lisa K McNeil, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 24, 2006
Specific fungal exposures, allergic sensitization, and rhinitis in infantsMelissa Osborne, Tiina Reponen, Atin Adhikari, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2008
Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivoDavid I Bernstein, Nathalie Goyette, Rhonda Cardin, et al.
Pediatrics|July 11, 2012
Vaccine-type human papillomavirus and evidence of herd protection after vaccine introductionJessica A Kahn, Darron R Brown, Lili Ding, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2016
Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a CommunityJessica A Kahn, Lea E Widdice, Lili Ding, et al.
Allergy and Asthma Proceedings|January 6, 2021
Allergy to oak pollen in North AmericaDavid I Bernstein, Peter A Würtzen, Lawrence DuBuske, et al.
Vaccine|September 14, 2019
Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpesDavid I Bernstein, Rhonda D Cardin, Fernando J Bravo, et al.
Pageof 38